A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model.Post author:caolab75@gmail.comPost published:August 15, 2008Post category:Articles15902.full_ You Might Also Like Peroxisomal abnormalities and catalase deficiency in Hutchinson-Gilford Progeria Syndrome. March 31, 2020 Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1 April 10, 2014 From Cellular Characteristics to Disease Diagnosis: Uncovering Phenotyps with Supercells. September 5, 2013
Peroxisomal abnormalities and catalase deficiency in Hutchinson-Gilford Progeria Syndrome. March 31, 2020
Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1 April 10, 2014
From Cellular Characteristics to Disease Diagnosis: Uncovering Phenotyps with Supercells. September 5, 2013
